BioAge Developing a Novel Class of Potent NLRP3 Inhibitors With Distinct Structural and Pharmacologic Properties for Inflammatory and Age-Related Diseases
New compounds specifically inhibit NLRP3 in mouse models and human cells Series includes orally active…